title: To tube or not to tube babies with respiratory distress syndrome.
abstract: The use of mechanical ventilation in premature infants with respiratory distress syndrome (RDS) and respiratory failure often results in barotrauma, volutrauma and chronic lung disease (CLD). Research indicates that early surfactant therapy and initiation of nasal continuous positive airway pressure (CPAP) for these infants significantly reduces the need for mechanical ventilation and the incidence of CLD. Different CPAP delivery systems exist, each with some practical and clinical advantages and disadvantages. Clinical trials indicate that optimal management of neonatal RDS could be improved by early surfactant treatment followed immediately by extubation and stabilization on CPAP. Evidence suggests a synergistic effect between early surfactant administration (within 2 h of birth) and rapid extubation to nasal CPAP with a significant reduction in the need for mechanical ventilation and its associated morbidities.
authors.affiliation: Department of Pediatrics, Neonatal-Perinatal Medicine, Neonatal Intensive Care Unit, Infant Breathing Disorders Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA. kris-sekar@ouhsc.edu
authors.forename: K C
authors.initials: KC
authors.lastname: Sekar
authors.forename: K E
authors.initials: KE
authors.lastname: Corff
mesh_terms: D001997:Bronchopulmonary Dysplasia; D003131:Combined Modality Therapy; D045422:Continuous Positive Airway Pressure / Q000295:instrumentation*; D006801:Humans; D007231:Infant, Newborn; D015931:Intensive Care, Neonatal / Q000379:methods*; D007442:Intubation, Intratracheal; D011663:Pulmonary Surfactants / Q000008:administration & dosage; D016032:Randomized Controlled Trials as Topic; D012127:Respiratory Distress Syndrome, Newborn / Q000628:therapy*
chemical_list: D011663:Pulmonary Surfactants